Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.
about
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactationAntidepressant use in pregnancy: a critical review focused on risks and controversiesPrenatal antidepressant exposure: clinical and preclinical findings.Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.Perinatal Generalized Anxiety Disorder: Assessment and Treatment.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study.Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.
P2860
Q26795384-3310F0B8-5BDF-4A19-BF1A-803ABD76FAF1Q28281407-BE6D3DE2-AEF9-4F05-A9EB-B2349666D474Q30415540-EF6E968F-171F-4F7D-8CAA-04489CC118C5Q33801507-A2F5281B-A67A-4032-922A-90BE36DE70A6Q34047430-75EE65C9-3EDD-4C4F-87D2-2E0EE6FAF778Q34483257-386304FD-8A1D-4693-B0FC-C928548C75DEQ35640425-69FEFBB0-3DD7-4EAC-8AE2-4DB5FBA03929Q35640478-6CA81E23-B9A2-46E1-8F4F-481C0CE6B346Q36108616-54E49060-9695-4B53-B905-95CE98119D97Q37337705-F43AD8EC-FE07-4AB2-BBBF-8C7A8D70704BQ41333984-42B34577-7EAA-429E-A2C7-780887E5D709Q48896306-F525FC1A-ADFF-4C1F-9CBE-DD8162238A94Q53107393-895DFC42-A339-4918-8637-440ED4C58323
P2860
Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@en
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@nl
type
label
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@en
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@nl
prefLabel
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@en
Fluoxetine and infantile hyper ...... g exposure surveillance study.
@nl
P2093
P356
P1476
Fluoxetine and infantile hyper ...... ug exposure surveillance study
@en
P2093
Bob Wilffert
Hermien E K De Walle
Lolkje T W de Jong-Van den Berg
P2860
P304
P356
10.1002/PDS.1964
P577
2010-08-01T00:00:00Z